Attached files
| file | filename |
|---|---|
| EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 - Cidara Therapeutics, Inc. | exhibit3122020-12.htm |
| EX-32.2 - CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002 - Cidara Therapeutics, Inc. | exhibit3222020-12.htm |
| EX-32.1 - CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 - Cidara Therapeutics, Inc. | exhibit3212020-12.htm |
| EX-31.1 - CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 - Cidara Therapeutics, Inc. | exhibit3112020-12.htm |
| EX-21.1 - LIST OF SUBSIDIARIES OF THE REGISTRANT - Cidara Therapeutics, Inc. | exhibit2112020-12.htm |
| EX-10.23 - THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT - Cidara Therapeutics, Inc. | exhibit10232020-12.htm |
| 10-K - CIDARA THERAPEUTICS, INC. 2020 FORM 10-K - Cidara Therapeutics, Inc. | cdtx-20201231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
a.Registration Statement (Form S-3 Nos. 333-211472, 333-221535, 333-225061, 333-225445, 333-225787, 333-228268, and 333-238955) of Cidara Therapeutics, Inc., and
b.Registration Statements (Form S-8 Nos. 333-203434, 333-210263, 333-216722, 333-228282, 333-231326, and 333-236874) pertaining to the 2013 Stock Option and Grant Plan, the 2015 Equity Incentive Plan, and the 2015 Employee Stock Purchase Plan of Cidara Therapeutics, Inc.;
of our report dated February 25, 2021, with respect to the consolidated financial statements of Cidara Therapeutics, Inc. included in this Annual Report (Form 10-K) of Cidara Therapeutics, Inc. for the year ended December 31, 2020.
/s/ Ernst & Young LLP
San Diego, California
February 25, 2021